Representatives of HALMED in the Netherlands at the workshop on reporting adverse reactions by patients
21.03.2012
Representatives of the Croatian Agency for Medicinal Products and Medical Devices participated from 7th to 9th March 2012 at the workshop on reporting of adverse reactions by patients which was held within the Monitoring Medicines Project organised by a consortium of organisations in the field of pharmacovigilance and led by World Health Organisation. The workshop was held in the City of 's-Hertogenbosch in the Kingdom of the Netherlands and hosted by the Dutch National Pharmacovigilance Centre - LAREB.
An application adopted to patient needs for reporting of adverse reactions was presented within the workshop by Uppsala Monitoring Centre which is a collaborating centre of World Health Organisation.
It is with pleaseure that we may inform that the Croatian Agency for Medicinal Products and Medical Devices (HALMED) will be among the first organisations in the world having the opportunity to test and to implement that application and hence facilitate the more active patients role in medicines safety monitoring.
The workshop at which representatives from national pharmacovigilance centres, competent authorities and representatives from patient organisations and associations participated, adopted a clear scientific evidence of the value of patients reporting, especially in detecting and identifying safety signals. Furthermore, the importance of collaboration of national centres, competent authorities and patient associations in promoting patient reporting of adverse reactions was emphasized.
